Ainos signs VELDONA license deal with BioPhoenix worth up to $10 million
Bitget2026/09/24 12:00- Ainos signed a VELDONA license deal with BioPhoenix, setting a conditional collaboration framework valued at up to USD 10 million.
- BioPhoenix secured exclusive worldwide rights for Sjögren's disease and thrombocytopenia, covering development, manufacturing, and commercialization.
- BioPhoenix will fund and run assigned clinical and regulatory work, shifting late-stage development costs away from Ainos.
- Framework includes an upfront license fee, potential payments for up to 15 additional indications, and a one-time fee on BioPhoenix’s first sublicense.
- Ainos will receive 25% of applicable net sublicensing revenue, separate from license fees and any product supply revenue.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AERO price prediction – Identifying the next short-term target for the altcoin
Swiss Franc remains near 16-month lows as rate hike odds lift US Dollar
Rapid rise in real interest rates, Goldman Sachs warns that 'systematic selling pressure' in US stocks is building at quarter-end
Goldman Sachs believes that the rapid rise in real interest rates has exerted more direct pressure on the US stock market, with rate-sensitive sectors such as small-cap and financial stocks being particularly affected. On the liquidity front, Goldman Sachs estimates that pension funds may sell around $3.3 billions in equities at the end of the month and quarter, and that CTAs may sell about $530 million worth of Russell 2000 index futures in the coming week. For the market, unless the issues of oil and interest rates are resolved, the AI narrative is "almost irrelevant."
USD/JPY falls below 157! The yen becomes the strongest G-10 currency, with the market betting on another rate hike by the central bank next month.
On Wednesday, the yen strengthened against the US dollar, with the USD/JPY rate falling below the 157 mark, as repeated warnings from the Japanese government regarding exchange rates and end-of-quarter capital flows provided support for the yen.
Crypto prices
More
